We begin with an overview of the several mutations of NR2F1 identified to date, then further focuses on the main pathological features of BBSOAS patients, providing evidence—whenever possible—for the existing genotype–phenotype correlations. This evidence concerns the gene NR2F1 and Bosch-Boonstra-Schaaf optic atrophy syndrome.